STAND. COM. REP. NO.  1566

 

Honolulu, Hawaii

                , 2017

 

RE:   S.B. No. 174

      S.D. 2

      H.D. 2

 

 

 

 

Honorable Joseph M. Souki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2017

State of Hawaii

 

Sir:

 

     Your Committee on Judiciary, to which was referred S.B. No. 174, S.D. 2, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO MEDICAL MARIJUANA,"

 

begs leave to report as follows:

 

     The purpose of this measure is to add lupus, epilepsy, multiple sclerosis, arthritis, and autism to the list of debilitating medical conditions that qualify for the legal use of medical marijuana in the State.

 

     The Drug Policy Forum of Hawaii, Community Alliance on Prisons, Hawaii Educational Association for Licensed Therapeutic Healthcare, Drug Policy Action Group, and several individuals testified in support of this measure.  The Department of Health, City and County of Honolulu Department of the Prosecuting Attorney, and Coalition for a Drug-Free Hawaii opposed this measure.  An individual submitted comments on this measure.

 

     Your Committee has amended this measure by:

 

(1)  Deleting autism from the list of debilitating medical conditions that qualify for the legal use of medical marijuana in the State; and

 

(2)  Making conforming amendments and other technical, nonsubstantive amendments for clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 174, S.D. 2, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as S.B. No. 174, S.D. 2, H.D. 2.

 

Respectfully submitted on behalf of the members of the Committee on Judiciary,

 

 

 

 

____________________________

SCOTT Y. NISHIMOTO, Chair